[Iatrogenic muscular fibrosis: experimental approach].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002701:Chloramphenicol / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology*; D007273:Injections, Intramuscular / Q000009:adverse effects; D008297:Male; D009132:Muscles / Q000473:pathology*; D009135:Muscular Diseases / Q000139:chemically induced*; D009336:Necrosis; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects; D051381:Rats
D000900:Anti-Bacterial Agents; D010406:Penicillins; D002701:Chloramphenicol; D006493:Heparin
Fibrosis muscular yatrogénica: aproximación experimental.